Cargando…
LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing
Liver X receptors (LXRs) are important regulators of cholesterol metabolism and inflammatory responses. LXR agonists exhibit potently anti-inflammatory effects in macrophages, which make them beneficial to anti-atherogenic therapy. In addition to transrepressive regulation by SUMOylation, LXRs can i...
Autores principales: | Li, Ni, Li, Yan, Han, Xiaowan, Zhang, Jing, Han, Jiangxue, Jiang, Xinhai, Wang, Weizhi, Xu, Yang, Xu, Yanni, Fu, Yu, Si, Shuyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614042/ https://www.ncbi.nlm.nih.gov/pubmed/36313296 http://dx.doi.org/10.3389/fphar.2022.973612 |
Ejemplares similares
-
Limiting of the Innate Immune Response by SF3A-Dependent Control of MyD88 Alternative mRNA Splicing
por: De Arras, Lesly, et al.
Publicado: (2013) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022) -
METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide‐induced inflammatory response in human dental pulp cells
por: Feng, Zhihui, et al.
Publicado: (2018) -
Alternative activation of macrophages by filarial nematodes is MyD88-independent
por: Mylonas, Katie J., et al.
Publicado: (2013) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021)